Process integration for emerging challenges: optimal allocation of antivirals under resource constraints

ABSTRACT: The global scientific community has intensified efforts to develop, test, and commercialize pharmaceutical products to deal with the COVID-19 pandemic. Trials for both antivirals and vaccines are in progress; candidates include existing repurposed drugs that were originally developed for o...

Descripción completa

Detalles Bibliográficos
Autores principales: Sy, C. L., Aviso, K. B., Cayamanda, C. D., Chiu, A. S. F., Lucas, R. I. G., Promentilla, M. A. B., Razon, L. F., Tan, R. R., Tapia, J. F. D., Torneo, A. R., Ubando, A. T., Yu, D. E. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292799/
https://www.ncbi.nlm.nih.gov/pubmed/32837502
http://dx.doi.org/10.1007/s10098-020-01876-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292799/
https://www.ncbi.nlm.nih.gov/pubmed/32837502
http://dx.doi.org/10.1007/s10098-020-01876-1

Ejemplares similares